Comparing two versions of a medicine after a meal in healthy men
Part of Kidney & urinary clinical trials.
This trial compares two versions of a medicine (AD-116A and AD-1161) to see if they work the same in the body when taken after eating. It is for healthy adult men to help ensure the new version is as good as the original.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult male aged 19 years or older.
- Weigh at least 50 kg (about 110 pounds).
- Have a body mass index (BMI) between 18.0 and 30.0.
- Not have taken part in another clinical trial with an investigational drug in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if two different versions of the study drug AD-116A work the same way in the body. It only includes healthy adult men, so it's not a treatment for a specific disease but helps confirm the drug's safety and absorption.
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
This study will compare two versions of a drug (called AD-117 and AD-117A) to see how your body processes them and whether they are safe. You would receive one version and then the other, to compare their effects.
This study compares an investigational medication (AJU-G721) to an approved reference medication (G721R) to see if they work the same in the body. It is for healthy volunteers and is done after eating a meal, to check how the medication is absorbed.
This trial tests a new version of a medicine (AD-228B) against the original (AD-2284) to see how they work in the body and if they are safe. Healthy volunteers are needed.
This trial compares two forms of a study drug to see how they are absorbed and cleared from the body, and to check their safety. It is for healthy volunteers and may help the company decide which version to develop further.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.